ReviewMolecular nutrition & food research2025
Impact of Nutrition on Sphingolipid-Regulated Physiology: A Review.
Review in Molecular nutrition & food research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Towards spatial lipid profiling by using mass spectrometry: analytical challenges and applications.Analytical and bioanalytical chemistry · 2026Review
- Diet-Induced Ceramide Remodeling as a Mechanistic Link to Cardiac Metabolic Dysfunction.Nutrients · 2026Review
- Nutrition and gut-brain axis: opposing effects of dietary fiber and Western-style diets on Alzheimer's disease.Current opinion in clinical nutrition and metabolic care · 2026Review
- C16-ceramide modulates sex-dimorphic defense strategies under cold stress in Cherax quadricarinatus via JAK-STAT suppression and oxidative disruption.Biology of sex differences · 2026Article
- Sphingolipids in Emotional Well-Being.Journal of neurochemistry · 2026Review
- Impact of Nutrition on Sphingolipid-Regulated Physiology: A Review.Molecular nutrition & food research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Sphingolipids (SLs) are a very diverse group of lipids already described by German physician Johann Thudichum in 1884. The name of these lipids originates from their (at the time) enigmatic nature and lack of knowledge about their cellular function, which was compared to the creature sphinx in Greek mythology. Today we know that SLs play an important role in a plethora of physiological and cellular processes, including tissue development, growth regulation, apoptosis, adhesion, cell migration, cell senescence, receptor signaling, and hormonal effects and are associated with multiple pathological processes in many different disease contexts. In addition to roles for specific SLs in developmental processes, their critical role in causing and preventing metabolic diseases, including cardiovascular disease, obesity, and diabetes during adulthood, has been uncovered through targeted genetic manipulation, lipidomics, and advanced biochemical analyses such as lipid-protein interactomics. Notably, in the context of maternal and paternal effects on offspring and their risk for metabolic disease, there is a gap in our knowledge regarding SLs in transgenerational disease mechanisms. This review summarizes our knowledge on SL metabolism and cellular roles in health and disease, while focusing on the current knowledge of dietary effects on SL-controlled metabolism of adults and their developing offspring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.